Seer EDS Usability Study Protocol

Overview

About this study

The purpose of this study is to demonstrate that the Seer Epilepsy Diagnostic System (EDS) medical device can be used for its intended use by the intended users without serious use errors or problems.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Any gender.
Age over 4 years.
Have read, understood and signed the approved informed consent form (parent or legal guardian must sign for anyone younger than 18 years).
Willing to use the Seer EDS as instructed and provide feedback.

Exclusion Criteria:

Subjects considered by the participating site to be unable to operate the medical device due to cognitive or physical impairment.

Eligibility last updated 9/16/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Benjamin Brinkmann, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Benjamin Brinkmann, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials